[go: up one dir, main page]

WO2003060103A3 - Minimal dna binding domain polynucleotides, polypeptides, and uses thereof - Google Patents

Minimal dna binding domain polynucleotides, polypeptides, and uses thereof Download PDF

Info

Publication number
WO2003060103A3
WO2003060103A3 PCT/US2003/000915 US0300915W WO03060103A3 WO 2003060103 A3 WO2003060103 A3 WO 2003060103A3 US 0300915 W US0300915 W US 0300915W WO 03060103 A3 WO03060103 A3 WO 03060103A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding domain
dna binding
polypeptides
minimal dna
domain polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/000915
Other languages
French (fr)
Other versions
WO2003060103A2 (en
Inventor
Subba Reddy Palli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rheogene Inc
Original Assignee
Rheogene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rheogene Inc filed Critical Rheogene Inc
Priority to AU2003202965A priority Critical patent/AU2003202965A1/en
Publication of WO2003060103A2 publication Critical patent/WO2003060103A2/en
Anticipated expiration legal-status Critical
Publication of WO2003060103A3 publication Critical patent/WO2003060103A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a novel isolated polynucleotide encoding a minimal GAL4 DNA binding domain polypeptide. The invention also relates to vectors comprising the polynucleotide and to uses thereof, in particular in methods for gene expression, particularly in the context of gene therapy.
PCT/US2003/000915 2002-01-14 2003-01-13 Minimal dna binding domain polynucleotides, polypeptides, and uses thereof Ceased WO2003060103A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003202965A AU2003202965A1 (en) 2002-01-14 2003-01-13 Minimal dna binding domain polynucleotides, polypeptides, and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34842702P 2002-01-14 2002-01-14
US60/348,427 2002-01-14

Publications (2)

Publication Number Publication Date
WO2003060103A2 WO2003060103A2 (en) 2003-07-24
WO2003060103A3 true WO2003060103A3 (en) 2004-09-23

Family

ID=23367999

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/000915 Ceased WO2003060103A2 (en) 2002-01-14 2003-01-13 Minimal dna binding domain polynucleotides, polypeptides, and uses thereof

Country Status (2)

Country Link
AU (1) AU2003202965A1 (en)
WO (1) WO2003060103A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101413799B1 (en) * 2005-10-27 2014-06-30 산토리 홀딩스 가부시키가이샤 Plants that accumulate inorganic phosphoric acid and use thereof
US9526768B2 (en) 2014-11-13 2016-12-27 Jennifer Mai Compositions for the treatment of cancer
CN109182359B (en) * 2018-10-09 2020-07-07 南京农业大学 A pear cold resistance gene PbrBAM3 and its expression vector, application and encoded protein and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939442A (en) * 1995-06-07 1999-08-17 The Salk Institute For Biological Studies Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof
US6255558B1 (en) * 1996-02-14 2001-07-03 Btg International Limited Gene expression

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939442A (en) * 1995-06-07 1999-08-17 The Salk Institute For Biological Studies Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof
US6255558B1 (en) * 1996-02-14 2001-07-03 Btg International Limited Gene expression

Also Published As

Publication number Publication date
WO2003060103A2 (en) 2003-07-24
AU2003202965A8 (en) 2003-07-30
AU2003202965A1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2003054152A3 (en) Novel nucleic acids and polypeptides
WO2003025148A3 (en) Novel nucleic acids and polypeptides
WO2002070539A3 (en) Novel nucleic acids and polypeptides
WO2003023013A3 (en) Novel nucleic acids and polypeptides
WO2002081731A3 (en) Novel nucleic acids and polypeptides
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2003020894A3 (en) Insulin related transcription factor and uses thereof
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2002018424A3 (en) Nucleic acids and polypeptides
WO2001079449A3 (en) Novel nucleic acids and polypeptides
WO2005049806A3 (en) Novel nucleic acids and polypeptides
WO2003093434A3 (en) Nanoarchaeum nucleic acid molecule
WO2003060103A3 (en) Minimal dna binding domain polynucleotides, polypeptides, and uses thereof
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO2001075093A8 (en) Novel nucleic acids and polypeptides
WO2001087917A8 (en) Novel nucleic acids and polypeptides
WO2003074675A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
WO2005026207A3 (en) Adipocyte complement related protein zacrp12

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP